https://orcid.org/0000-0002-9686-3067
References
- 17th World Conference on Tobacco or Health. Cape Town declaration on human rights and a tobacco-free world; 2018. Available from: https://unfairtobacco.org/en/cape-town-declaration/. Accessed October 15, 2021.
- Murray CJL, Aravkin AY, Zheng P, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1223–1249.
- Zafeiridou M, Hopkinson NS, Voulvoulis N. Cigarette smoking: an assessment of tobacco’s global environmental footprint across its entire supply chain. Environ Sci Technol. 2018;52:8087–8094. doi:10.1021/acs.est.8b01533
- UN Development Programme. The WHO framework convention on tobacco control an accelerator for sustainable development; 2017. Available from: http://www.undp.org/content/undp/en/home/librarypage/hiv-aids/-the-who-framework-convention-on-tobacco-control-an-accelerator-.html. Accessed October 15, 2021.
- Philip Morris International. Investor information July 2021; 2021. Available from: https://philipmorrisinternational.gcs-web.com/static-files/ded59402-2667-402a-9635-40579f0eaa40. Accessed October 15, 2021.
- Agrawal S. Proposed takeover of Vectura by Philip Morris International. BMJ. 2021;374:n2235.
- European Respiratory Society. ERS response to the proposed acquisition of Vectura by Philip Morris International; 2021. Available from: https://www.ersnet.org/news-and-features/news/ers-response-to-the-proposed-acquisition-of-vectura-by-philip-morris-international/. Accessed October 15, 2021.
- British Thoracic Society. BTS statement: proposed takeover of Vectura by Philip Morris International; 2021. Available from: https://www.brit-thoracic.org.uk/news/2021/bts-statement-proposed-takeover-of-vectura-by-philip-morris-international/. Accessed October 15, 2021.
- Vectura. Vectura PLC - track record; 2021. Available from: https://www.vectura.com/about-vectura/track-record/. Acccessed August 20, 2021.
- Vectura. Vectura Group plc annual report and accounts 2020; 2021. Available from: https://www.vectura.com/wp-content/uploads/2021/04/Vectura-Group-plc-Annual-Report-and-Accounts-2020.pdf. Accessed August 20, 2021.
- National Institute for Clinical Excellence. Shared decision making - NICE guideline [NG197]; 2021. Available from: https://www.nice.org.uk/guidance/NG197. Accessed October 15, 2021.
- All Party Parliamentary Group on Smoking and Health. Delivering a smokefree 2030: the all party parliamentary group on smoking and health recommendations for the tobacco control plan 2021; 2021. Available from: https://ash.org.uk/about-ash/all-party-parliamentary-group-on-smoking-health/inquiries-reports/deliveringasf2030appgtcp2021/. Accessed October 15, 2021.
- Hopkinson NS, Molyneux A, Pink J, et al. Chronic obstructive pulmonary disease: diagnosis and management: summary of updated NICE guidance. BMJ. 2019;366:l4486. doi:10.1136/bmj.l4486
- Crompton GK, Barnes PJ, Broeders M, et al. The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team. Respir Med. 2006;100:1479–1494. doi:10.1016/j.rmed.2006.01.008
- Lavorini F, Magnan A, Christophe Dubus J, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med. 2008;102:593–604. doi:10.1016/j.rmed.2007.11.003
- Usmani O, Capstick T, Saleem A, et al. Choosing an appropriate inhaler device for the treatment of adults with asthma or COPD; 2020. Available from: https://www.guidelines.co.uk/respiratory/inhaler-choice-guideline/455503.article. Accessed October 15, 2021.
- Moodie C, Sinclair L, Mackintosh AM, et al. How tobacco companies are perceived within the United Kingdom: an online panel. Nicotine Tob Res. 2016;18:1766–1772. doi:10.1093/ntr/ntw024
- Liew K, Wilkinson A. P280 How do we choose inhalers? Patient and physician perspectives on environmental, financial and ease-of-use factors. Thorax. 2017;72:A235–A237.
- Fulton O. Tweet about PMI takeover of Vectura; 2021. Available from: https://twitter.com/just_TUX/status/1426450284851630081?s=20. Accessed October 15, 2021.
- Cummings KM. A promise is a promise. Tob Control. 2003;12:117–118. doi:10.1136/tc.12.2.117
- The McKinsey Global Institute. Overcoming obesity: an initial economic analysis; 2014. Available from: http://www.mckinsey.com/insights/economic_studies/how_the_world_could_better_fight_obesity. Accessed October 15, 2021.
- Hopkinson NS. The path to a smoke-free England by 2030. BMJ. 2020;368:m518. doi:10.1136/bmj.m518
- Vectura. Vectura highlights update made by Hikma on launch of generic Advair Diskus®; 2021. Available from: https://ir.q4europe.com/Solutions/VecturaIntranet/3832/newsArticle.aspx?storyid=15036321. Accessed October 15, 2021.
- Rowex. Package leaflet: AirBuFo® Forspiro® 160 microgram/4.5 microgram/dose inhalation powder, pre-dispensed. last revision; 2018. Available from: https://www.hpra.ie/img/uploaded/swedocuments/2208694.PA0711_284_001.418b6375-936e-4333-b543-e4c22f605a13.000001AirBuFo%20PIL.180731.pdf. Accessed October 15, 2021.